CytoMed Therapeutics Limited Increase Decrease Through Modification Of Contractual Cash Flows Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts
CytoMed Therapeutics Limited (GDTC) reported Increase Decrease Through Modification Of Contractual Cash Flows Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts of SGD 1.70 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughModificationOfContractualCashFlowsExposureToCreditRiskOnLoanCommitmentsAndFinancialGuaranteeContracts · last filed 2026-03-31
| Period end | Increase Decrease Through Modification Of Contractual Cash Flows Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts 12 month |
|---|---|
| 2025-12-31 | 1.70K SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 1.70K SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 1.80K SGD 20-F · filed 2025-04-28 |
| 2022-12-31 | 2.00K SGD 20-F · filed 2024-04-22 |
| 2021-12-31 | 2.30K SGD 20-F · filed 2023-05-01 |